» Articles » PMID: 15767404

Analysis of Human Immunodeficiency Virus Cytopathicity by Using a New Method for Quantitating Viral Dynamics in Cell Culture

Overview
Journal J Virol
Date 2005 Mar 16
PMID 15767404
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Human immunodeficiency virus (HIV) causes complex metabolic changes in infected CD4(+) T cells that lead to cell cycle arrest and cell death by necrosis. To study the viral functions responsible for deleterious effects on the host cell, we quantitated the course of HIV type 1 infection in tissue cultures by using flow cytometry for a virally encoded marker protein, heat-stable antigen (HSA). We found that HSA appeared on the surface of the target cells in two phases: passive acquisition due to association and fusion of virions with target cells, followed by active protein expression from transcription of the integrated provirus. The latter event was necessary for decreased target cell viability. We developed a general mathematical model of viral dynamics in vitro in terms of three effective time-dependent rates: those of cell proliferation, infection, and death. Using this model we show that the predominant contribution to the depletion of viable target cells results from direct cell death rather than cell cycle blockade. This allows us to derive accurate bounds on the time-dependent death rates of infected cells. We infer that the death rate of HIV-infected cells is 80 times greater than that of uninfected cells and that the elimination of the vpr protein reduces the death rate by half. Our approach provides a general method for estimating time-dependent death rates that can be applied to study the dynamics of other viruses.

Citing Articles

Quantifying T lymphocyte turnover.

De Boer R, Perelson A J Theor Biol. 2013; 327:45-87.

PMID: 23313150 PMC: 3640348. DOI: 10.1016/j.jtbi.2012.12.025.


Quantification system for the viral dynamics of a highly pathogenic simian/human immunodeficiency virus based on an in vitro experiment and a mathematical model.

Iwami S, Holder B, Beauchemin C, Morita S, Tada T, Sato K Retrovirology. 2012; 9:18.

PMID: 22364292 PMC: 3305505. DOI: 10.1186/1742-4690-9-18.


Multi-scale modeling of HIV infection in vitro and APOBEC3G-based anti-retroviral therapy.

Hosseini I, Mac Gabhann F PLoS Comput Biol. 2012; 8(2):e1002371.

PMID: 22346743 PMC: 3276540. DOI: 10.1371/journal.pcbi.1002371.


Estimating frequencies of minority nevirapine-resistant strains in chronically HIV-1-infected individuals naive to nevirapine by using stochastic simulations and a mathematical model.

Gadhamsetty S, Dixit N J Virol. 2010; 84(19):10230-40.

PMID: 20668070 PMC: 2937761. DOI: 10.1128/JVI.01010-10.


Timing the emergence of resistance to anti-HIV drugs with large genetic barriers.

Arora P, Dixit N PLoS Comput Biol. 2009; 5(3):e1000305.

PMID: 19282958 PMC: 2643484. DOI: 10.1371/journal.pcbi.1000305.


References
1.
Ameisen J, Capron A . Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol Today. 1991; 12(4):102-5. DOI: 10.1016/0167-5699(91)90092-8. View

2.
Stewart S, Poon B, Jowett J, Xie Y, Chen I . Lentiviral delivery of HIV-1 Vpr protein induces apoptosis in transformed cells. Proc Natl Acad Sci U S A. 1999; 96(21):12039-43. PMC: 18408. DOI: 10.1073/pnas.96.21.12039. View

3.
Pantaleo G, Graziosi C, Fauci A . The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med. 1993; 328(5):327-35. DOI: 10.1056/NEJM199302043280508. View

4.
Pantaleo G, Graziosi C, Demarest J, Butini L, Montroni M, Fox C . HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature. 1993; 362(6418):355-8. DOI: 10.1038/362355a0. View

5.
Levy J . Pathogenesis of human immunodeficiency virus infection. Microbiol Rev. 1993; 57(1):183-289. PMC: 372905. DOI: 10.1128/mr.57.1.183-289.1993. View